Strasser JE - Search Results

1

Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.

Gamage SD, Strasser JE, Chalk CL, Weiss AA. Gamage SD, et al. Among authors: strasser je. Infect Immun. 2003 Jun;71(6):3107-15. doi: 10.1128/IAI.71.6.3107-3115.2003. Infect Immun. 2003. PMID: 12761088 Free PMC article.

2

Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.

Gamage SD, Patton AK, Strasser JE, Chalk CL, Weiss AA. Gamage SD, et al. Among authors: strasser je. Infect Immun. 2006 Mar;74(3):1977-83. doi: 10.1128/IAI.74.3.1977-1983.2006. Infect Immun. 2006. PMID: 16495578 Free PMC article.

3

Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.

Flagler MJ, Strasser JE, Chalk CL, Weiss AA. Flagler MJ, et al. Among authors: strasser je. Infect Immun. 2007 Feb;75(2):760-5. doi: 10.1128/IAI.01594-06. Epub 2006 Nov 13. Infect Immun. 2007. PMID: 17101648 Free PMC article.

4

Shiga toxin subtypes display dramatic differences in potency.

Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA. Fuller CA, et al. Among authors: strasser je. Infect Immun. 2011 Mar;79(3):1329-37. doi: 10.1128/IAI.01182-10. Epub 2011 Jan 3. Infect Immun. 2011. PMID: 21199911 Free PMC article.

5

Potent adjuvant activity of cationic liposome-DNA complexes for genital herpes vaccines.

Bernstein DI, Cardin RD, Bravo FJ, Strasser JE, Farley N, Chalk C, Lay M, Fairman J. Bernstein DI, et al. Among authors: strasser je. Clin Vaccine Immunol. 2009 May;16(5):699-705. doi: 10.1128/CVI.00370-08. Epub 2009 Mar 11. Clin Vaccine Immunol. 2009. PMID: 19279167 Free PMC article.

6

A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo.

Carey B, DeLay M, Strasser JE, Chalk C, Dudley-McClain K, Milligan GN, Brunner HI, Thornton S, Hirsch R. Carey B, et al. Among authors: strasser je. Clin Immunol. 2005 Jul;116(1):65-76. doi: 10.1016/j.clim.2005.02.013. Clin Immunol. 2005. PMID: 15925833

7

Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.

Dobbs ME, Strasser JE, Chu CF, Chalk C, Milligan GN. Dobbs ME, et al. Among authors: strasser je. J Virol. 2005 Dec;79(23):14546-54. doi: 10.1128/JVI.79.23.14546-14554.2005. J Virol. 2005. PMID: 16282454 Free PMC article.

8

Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.

Chu CF, Meador MG, Young CG, Strasser JE, Bourne N, Milligan GN. Chu CF, et al. Among authors: strasser je. J Reprod Immunol. 2008 Jun;78(1):58-67. doi: 10.1016/j.jri.2007.08.004. Epub 2007 Oct 24. J Reprod Immunol. 2008. PMID: 17950908 Free PMC article.

9

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs.

Strasser JE, Arnold RL, Pachuk C, Higgins TJ, Bernstein DI. Strasser JE, et al. J Infect Dis. 2000 Nov;182(5):1304-10. doi: 10.1086/315878. Epub 2000 Oct 4. J Infect Dis. 2000. PMID: 11023454

10

Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum.

Strasser JE, Newman SL, Ciraolo GM, Morris RE, Howell ML, Dean GE. Strasser JE, et al. J Immunol. 1999 May 15;162(10):6148-54. J Immunol. 1999. PMID: 10229858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters